Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating pyrotinib plus vinorelbine in HER2-positive metastatic breast cancer patients with brain metastases.
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial investigating intrathecal trastuzumab for leptomeningeal metastases in HER2-positive breast cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating ipilimumab and nivolumab in recurrent stage IV HER2-negative inflammatory breast cancer; study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer [Phase 3]
A phase 3 trial comparing conventional axillary dissection to sentinel node resection in clinically node-negative operable breast cancer has…
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers [Phase 2]
Phase 2 trial comparing neoadjuvant chemotherapy with and without Zometa in locally advanced breast cancer completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-05-24FDA Approved: PIQRAY — Original Application (Novartis Pharmaceuticals Corporation)
The FDA approved PIQRAY (alpelisib) as the original application by Novartis for use in adults with HR-positive, HER2-negative, PIK3CA-mutate…
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer [Phase 2]
Phase 2 clinical trial update for paclitaxel albumin-bound as neoadjuvant therapy in breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating metronomic low-dose cyclophosphamide and methotrexate with or without bevacizumab in metastatic breast cancer.
-
FDA approval · 2019-05-20FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for FASLODEX (fulvestrant) from AstraZeneca Pharmaceuticals LP, updating its labeling and/or indicat…
-
FDA approval · 2019-05-20FDA Approved: FULVESTRANT — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fulvestrant through an Original Application (NDA210326) for Fresenius Kabi USA, LLC.
-
FDA approval · 2019-05-19FDA Approved: LETROZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Letrozole submitted by Teva Pharmaceuticals USA, Inc., updating the label and/or indications…
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours [Phase 2]
A Phase 2 clinical trial in BRCA-defective tumors including breast and ovarian cancer has completed recruitment and posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer [Phase 3]
Phase 3 clinical trial assessing a surgical sealing patch and its effect on lymphatic drainage after axillary lymph node dissection in breas…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Metronomic Therapy in Metastatic Breast Cancer. [Phase 3]
Phase 3 clinical trial update on metronomic therapy for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating F511 Cream to prevent hand-foot syndrome in patients with metastatic breast cancer receiving liposomal doxorubicin.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy [Phase 2]
Phase 2 trial evaluating fulvestrant with or without AZD6244 in advanced breast cancer after aromatase inhibitor progression has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating trastuzumab with letrozole in postmenopausal women with progressive advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD) [Phase 3]
Phase 3 trial update evaluating cardiac safety and efficacy of pegylated liposomal doxorubicin in early-stage breast cancer.
-
FDA approval · 2019-05-14FDA Approved: FULVESTRANT — Original Application (Sandoz Inc)
The FDA approved Sandoz's original ANDA for fulvestrant, providing a generic version of the breast cancer therapy Fulvestrant.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer [Phase 1]
Phase 1 safety study of enzalutamide (MDV3100) in patients with incurable breast cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer [NA]
Clinical trial investigating enalapril maleate with doxorubicin hydrochloride in women with breast cancer has completed; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm [Phase 3]
Phase 3 clinical trial update on tailored neoadjuvant chemotherapy for stage II/III breast cancer with tumor size >2 cm has been completed.
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating lapatinib in combination with oral vinorelbine for metastatic breast cancer completed.
-
FDA approval · 2019-05-03FDA Approved: KADCYLA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for KADCYLA (ado-trastuzumab emtansine) submitted by Genentech, Inc., regarding an amendment to the …
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer [Phase 2]
Phase 2b study evaluating Taxol plus sorafenib or placebo in advanced breast cancer.